Titel

Merkliste
1 Ergebnisse

Biotechnological Agents for Patients With Tumor Necrosis Fa..:

Antonio Vitale ; Laura Obici ; Marco Cattalini...
https://www.frontiersin.org/articles/10.3389/fmed.2021.668173/full. , 2021

Link: https://doi.org/10.3389/fmed.2021.668173

RT Journal
T1 <Title>Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:5c0a3951700142319be2e2e7c72002f8&Exemplar=1&LAN=DE
				
A1 Antonio Vitale
A1 Laura Obici
A1 Marco Cattalini
A1 Giuseppe Lopalco
A1 Giampaolo Merlini
A1 Nicola Ricco
A1 Alessandra Soriano
A1 Francesco La Torre
A1 Elena Verrecchia
A1 Antonella Insalaco
A1 Lorenzo Dagna
A1 Masen Abdel Jaber
A1 Davide Montin
A1 Giacomo Emmi
A1 Luisa Ciarcia
A1 Sara Barneschi
A1 Paola Parronchi
A1 Piero Ruscitti
A1 Maria Cristina Maggio
A1 Ombretta Viapiana
A1 Jurgen Sota
A1 Carla Gaggiano
A1 Roberto Giacomelli
A1 Ludovico Luca Sicignano
A1 Raffaele Manna
A1 Alessandra Renieri
A1 Caterina Lo Rizzo
A1 Bruno Frediani
A1 Donato Rigante
A1 Luca Cantarini
PB Frontiers Media S.A.
YR 2021
K1 tumor necrosis factor receptor-associated periodic syndrome
K1 biologic therapy
K1 personalized medicine
K1 interleukin-1 inhibitors
K1 tumor necrosis factor inhibitors
K1 tocilizumab
K1 Medicine (General)
K1 R5-920
JF https://www.frontiersin.org/articles/10.3389/fmed.2021.668173/full
LK http://dx.doi.org/https://doi.org/10.3389/fmed.2021.668173
DO https://doi.org/10.3389/fmed.2021.668173
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)